These novel treatments, Retatrutide, represent a remarkable advancement in managing type 2 diabetes and potentially associated disorders. These drugs are classified as GLP-1 receptor activators , signifying they to replicate the natural GLP-1 hormone , boosting metabolic production and suppressing hunger . While Retatrutide each one operates somewh